Barbara Osimani

648 total citations
26 papers, 228 citations indexed

About

Barbara Osimani is a scholar working on Economics and Econometrics, Toxicology and Statistics and Probability. According to data from OpenAlex, Barbara Osimani has authored 26 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Economics and Econometrics, 9 papers in Toxicology and 6 papers in Statistics and Probability. Recurrent topics in Barbara Osimani's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmacovigilance and Adverse Drug Reactions (9 papers) and Statistical Methods in Clinical Trials (5 papers). Barbara Osimani is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmacovigilance and Adverse Drug Reactions (9 papers) and Statistical Methods in Clinical Trials (5 papers). Barbara Osimani collaborates with scholars based in Italy, Germany and Australia. Barbara Osimani's co-authors include Jürgen Landes, Fiorenzo Mignini, Adam La Caze, Claus Jacob, Federica Russo, Jon Williamson, Ciro Isidoro, Emanuele Frontoni, Colleen Aldous and Marta Bertolaso and has published in prestigious journals such as International Journal of Environmental Research and Public Health, Frontiers in Pharmacology and Current Pharmaceutical Design.

In The Last Decade

Barbara Osimani

24 papers receiving 210 citations

Peers

Barbara Osimani

TOXIC

SPU

GHP

Brendan Clarke United Kingdom

Alexander C. Egilman United States

Matthew Herder Canada

Phil Tregunno United Kingdom

Sanaa Al-Marzouki Saudi Arabia

Graham Lewis United Kingdom

Lois Ann Colaianni United States

Carrie E. Pierce United States

Lan Huang United States

Brian McCourt United States

Brendan Clarke United Kingdom

Barbara Osimani

72 ×0.8

9 ×0.2

TOXIC

43 ×1.1

SPU

31 ×0.8

84 ×2.4

GHP

Citations per year, relative to Barbara Osimani Barbara Osimani (= 1×) peers Brendan Clarke

Countries citing papers authored by Barbara Osimani

Since Specialization

Citations

This map shows the geographic impact of Barbara Osimani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Osimani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Osimani more than expected).

Fields of papers citing papers by Barbara Osimani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Osimani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Osimani. The network helps show where Barbara Osimani may publish in the future.

Co-authorship network of co-authors of Barbara Osimani

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Osimani. A scholar is included among the top collaborators of Barbara Osimani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Osimani. Barbara Osimani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aldous, Colleen, et al.. (2023). When Characteristics of Clinical Trials Require Per-Protocol as Well as Intention-to-Treat Outcomes to Draw Reliable Conclusions: Three Examples. Journal of Clinical Medicine. 12(11). 3625–3625. 4 indexed citations

Osimani, Barbara, et al.. (2022). Incentives for Research Effort: An Evolutionary Model of Publication Markets with Double-Blind and Open Review. Computational Economics. 61(4). 1433–1476. 13 indexed citations

Teodori, Laura, Barbara Osimani, Ciro Isidoro, & Seeram Ramakrishna. (2022). Mass versus personalized medicine againstCOVID‐19 in the “system sciences” era. Cytometry Part A. 101(12). 995–999. 3 indexed citations

Osimani, Barbara & Jürgen Landes. (2021). Varieties of Error and Varieties of Evidence. The British Journal for the Philosophy of Science.

Osimani, Barbara & Jürgen Landes. (2021). Varieties of Error and Varieties of Evidence in Scientific Inference. The British Journal for the Philosophy of Science. 74(1). 117–170. 5 indexed citations

Landes, Jürgen, et al.. (2020). Reliability: an introduction. Synthese. 198(S23). 5615–5624. 1 indexed citations

Landes, Jürgen & Barbara Osimani. (2020). On the Assessed Strength of Agents’ Bias. Journal for General Philosophy of Science. 51(4). 525–549. 2 indexed citations

Caze, Adam La & Barbara Osimani. (2020). Uncertainty in Pharmacology. Boston studies in the philosophy of science. 10 indexed citations

Landes, Jürgen, et al.. (2019). E-Synthesis: A Bayesian Framework for Causal Assessment in Pharmacosurveillance. Frontiers in Pharmacology. 10. 1317–1317. 15 indexed citations

10.

Landes, Jürgen, et al.. (2019). Reviewing the Mechanistic Evidence Assessors E-Synthesis and EBM+: A Case Study of Amoxicillin and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). Current Pharmaceutical Design. 25(16). 1866–1880. 13 indexed citations

11.

Osimani, Barbara, et al.. (2019). New Insights in Computational Methods for Pharmacovigilance: E-Synthesis, a Bayesian Framework for Causal Assessment. International Journal of Environmental Research and Public Health. 16(12). 2221–2221. 7 indexed citations

12.

Osimani, Barbara, et al.. (2018). Real and Virtual Clinical Trials: A Formal Analysis. Topoi. 38(2). 411–422. 3 indexed citations

13.

Osimani, Barbara. (2014). Safety vs. efficacy assessment of pharmaceuticals: Epistemological rationales and methods. Preventive Medicine Reports. 1. 9–13. 2 indexed citations

14.

Osimani, Barbara & Fiorenzo Mignini. (2014). Causal Assessment of Pharmaceutical Treatments: Why Standards of Evidence Should not be the Same for Benefits and Harms?. Drug Safety. 38(1). 1–11. 19 indexed citations

15.

Osimani, Barbara. (2013). Until RCT proven? On the asymmetry of evidence requirements for risk assessment. Journal of Evaluation in Clinical Practice. 19(3). 454–462. 23 indexed citations

16.

Osimani, Barbara. (2013). The precautionary principle in the pharmaceutical domain: a philosophical enquiry into probabilistic reasoning and risk aversion. Health Risk & Society. 15(2). 123–143. 18 indexed citations

17.

Osimani, Barbara, Federica Russo, & Jon Williamson. (2011). Scientific Evidence and the Law. 11(2). 1–24. 5 indexed citations

18.

Osimani, Barbara, et al.. (2011). Disability, Human Rights, and the International Classification of Functioning, Disability, and Health. American Journal of Physical Medicine & Rehabilitation. 91(13). S146–S154. 2 indexed citations

19.

Osimani, Barbara. (2010). Pharmaceutical risk communication: Sources of uncertainty and legal tools of uncertainty management. Health Risk & Society. 12(5). 453–469. 10 indexed citations

20.

Osimani, Barbara. (2007). The epistemic nature of package leaflet information. Open access LMU (Ludwid Maxmilian's Universitat Munchen).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact